Koji Maruyama

Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell–dependent antitumor effects

Christophe Borg, Magali Terme, Cédric Menard et al. · Journal of Clinical Investigation · 2004 · 284 citations

Integrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumors

Keiichi Ohshima, Keiichi Hatakeyama, Takeshi Nagashima et al. · Scientific Reports · 2017 · 132 citations · Full text

IL-4 Confers NK Stimulatory Capacity to Murine Dendritic Cells: A Signaling Pathway Involving KARAP/DAP12-Triggering Receptor Expressed on Myeloid Cell 2 Molecules

Magali Terme, Elena Tomasello, Koji Maruyama et al. · The Journal of Immunology · 2004 · 71 citations

Myeloid Cell 2, T-regulatory Cell, Karap/dap12-triggering Receptor +19

CD133-positive cancer stem cells from colo205 human colon adenocarcinoma cell line show resistance to chemotherapy and display a specific metabolomic profile

Vincent Zangiacomi, Kenichi Urakami, Koji Maruyama et al. · Genes & Cancer · 2014 · 48 citations · Full text

Cancer Stem-like Cells, Systems Biology, Oncology +13

Organotypic brain explant culture as a drug evaluation system for malignant brain tumors

Noriaki Minami, Yusuke Maeda, Shunsuke Shibao et al. · Cancer Medicine · 2017 · 36 citations · Full text